Concepedia

Ka Lai Yee

KL

39

Publications

1.3K

Citations

23

H-Index

2006

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Celerion (United States)

Medica (United States)

United States Military Academy

Orlando Clinical Research Center

Ka Lai Yee is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2006–2024

39

Publications

39

Effects of Suvorexant, an Orexin Receptor Antagonist, on Sleep Parameters as Measured by Polysomnography in Healthy Men

Hong Sun, William P. Kennedy, Darren Wilbraham et al. · SLEEP · 2013 · 158 citations · Full text

The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold

Anthony L. Gotter, Christopher J. Winrow, Joseph Brunner et al. · BMC Neuroscience · 2013 · 93 citations · Full text

Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man

Anthony L. Gotter, Mark S. Forman, C. Meacham Harrell et al. · Scientific Reports · 2016 · 78 citations · Full text

Characterisation of the absorption, distribution, metabolism, excretion and mass balance of doravirine, a non-nucleoside reverse transcriptase inhibitor in humans

Rosa I. Sánchez, Kerry L. Fillgrove, Ka Lai Yee et al. · Xenobiotica · 2018 · 56 citations

A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal Impairment

Daniel Tatosian, Ka Lai Yee, Zufei Zhang et al. · Clinical Pharmacology & Therapeutics · 2020 · 52 citations

Rows per page

1–5 of 39